WestChina-Frontier laboratories are equipped with advanced instruments and analysis software, establishing a leading biomarker analysis platform in China, an in vitro cardiac safety evaluation hERG technology platform based on manual patch clamp, a stem cell and organoid platform, a comprehensive in vitro Proarrhythmia Assay (CiPA) system for human stem cell differentiated cadiocytes.

We have established a pathology team consisting of multiple pathologists and skilled pathology technicians, many of whom hold Chinese Certified Veterinarian Pathologist (CCVP) qualifications. Our laboratory conducts GLP-compliant pathological tests; and standardized technical processes covering necropsy, tissue treatment, section preparation, and staining have been established...

Our clinical testing laboratory consists of multiple professionals with clinical laboratory technician qualification; we are dedicated to high-quality testing (including hematology, blood biochemistry, immunology, bone marrow and hematocyte morphology) of biological samples of a variety of experimental animal species.

The innovative small molecule drug toxicokinetic test platform featuring high sensitivity and specificity based on UPLC-MS/MS has been established for high-throughput, high-precision, high-efficiency, automation and trace-level research and technical services of chemical drugs and biological products. The platform is equipped with facilities and technical capabilities to analyze and determine the concentration of multiple biotech drugs in vivo simultaneously.

The receipt, storage, use, formulation preparation, analysis, distribution, recovery and disposal services of test articles have been provided in line with national laws and regulations, GLP standards, and applicable regulatory and code requirements. The storage and preparation of test articles and reference standards have been done in different areas for management; data automation has been implemented for liquid chromatography workstation and temperature (liquid level) monitoring.